4
Views
8
CrossRef citations to date
0
Altmetric
Original

Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: a 1-year prospective study in an Israeli clinic

, , , &
Pages 42-46 | Received 02 Jan 2003, Accepted 26 Sep 2003, Published online: 07 Aug 2009

References

  • Bell J, Mattick R, Hay A, Chan J, Hall W. Methadone maintenance and drug-related crime. Journal of Substance Abuse 1997; 9: 15–25
  • Brooner R, King V, Kidorf M, Schmidt C, Bigelow G. Psychiatric and substance use comorbidity among treatment seeking opioid abusers. Archives of General Psychiatry 1997; 54: 71–80
  • Corty E, Bal J. Admissions to methadone maintenance: comparisons between programs and implications for treatment. Journal of Substance Abuse Treatment 1987; 4: 181–187
  • Dupont R L, Saylor K E. Marijuana and benzodiazepines in patients receiving methadone treatment (letter). Journal of the American Medical Association 1989; 261: 3409
  • Nirenberg T D, Liepman M R, Cellucci T, Swift R M, Sirota A D. Cannabis versus other illicit drug use among methadone maintenance patients. Psychology of Addictive Behaviors 1996; 4: 222–227
  • Saxon A J, Calsyn D A, Greenberg D, Blaes P, Haver V M, Stanton V. Urine screening for marijuana among methadone maintenance patients. American Journal on Addictions 1993; 3: 207–211
  • Wolff K, Hay A W, Vail A, Harrison K, Raistrick D. Non-prescribed drug use during methadone treatment by clinic-and community-based patients. Addiction 1996; 91: 1699–1704
  • Kotzker E, Steer R A, Schut J. Differentiation of long-term methadone patients from their admission cohorts. International Journal of the Addictions 1979; 14: 281–287
  • Fairbank J A, Dunteman G H, Condelli W. Do methadone patients substitute other drugs for heroin? Predicting substance use at 1-year follow-up. American Journal of Drug and Alcohol Abuse 1993; 19: 465–474
  • Adelson M, Bleich A, Hayward R, Bodner G, Gelkopf M, Kreek M J. Replication of an effective opiate addiction pharmacotherapeutic treatment model: Minimal need for modification to a different country. Journal of Maintenance in the Addiction 2000; 1: 5–13
  • Bleich A, Gelkopf M, Hayward R, Schmidt V, Adelson M. Correlates of benzodiazepine abuse in methadone maintenance treatment patients: a 1-year prospective study in an Israeli clinic. Addiction 1999; 94: 1533–1540
  • Gelkopf M, Bleich A, Hayward R, Bodner G, Adelson M. Characteristics of benzodiazepine (BZD) abuse in methadone maintenance treatment (MMT) patients: a one year prospective study in an Israeli clinic. Drug and Alcohol Dependence 1999; 55: 63–68
  • Gelkopf M, Bleich A, Hayward R, Adelson M. Treatment outcomes after initiation of Sabbath closure of a methadone maintenance clinic. Psychiatric Services 1998; 49: 1483–1485
  • Weizman T, Gelkopf M, Melamed Y, Adelson M, Bleich A. Treatment of benzodiazepine dependence in methadone maintenance treatment patients: a comparison of two therapeutic modalities and the role of psychiatric comorbididty. Australian and New Zealand Journal of Psychiatry 2003; 37: 458–463
  • Cacciola J, Griffith J, Mclellan T A. ASI: instruction manual 4th edn. Veterans Administration, Washington, DC 1983
  • Hawks R L. Analytical methodology. Urine testing for drugs of abuse. NIDA Research Monograph, R L Hawks, C N Chiang, 1986; 73: 30–42
  • First M, Spitzer R, Gibbon M, et al. Structured clinical interview for axis 1 DSM-IV disorders. Patient edition. State Psychiatric Institute, New York 1994
  • Zanarini M C, Skodol A E, Bender D, et al. The Collaborative Longitudinal Personality Disorders Study: reliability of axis I and II diagnoses. Journal of Personality Disorders 2000; 14: 291–299
  • Derogatis L. SCL-90-R: administration, scoring and procedures: manual 1. Clinical Psychometric Research, Baltimore, MD 1977
  • Bundey A, Bickel W, Amass L. Marijuana use and treatment outcome among opioid- dependent patients. Addiction 1998; 93: 493–503
  • Dore G M, Walker J D, Paice J R, Clarkson S. Methadone maintenance treatment: outcomes from the Otago methadone programme. New Zealand Medical Journal 1999; 112: 442–445

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.